{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:33:20Z","timestamp":1793036000638,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Increasing evidence supports a key role for peripheral immune processes in the pathophysiology of Alzheimer\u2019s disease (AD), highlighting an intricate interplay between brain resident glial cells and both innate and adaptive peripheral immune effectors. We previously showed that regulatory T cells (Tregs) have a beneficial impact on disease progression in AD-like pathology, notably by modulating the microglial response associated with A\u03b2 deposits in a mouse model of amyloid pathology. Besides microglia, reactive astrocytes also play a critical role in neuroinflammatory processes associated with AD. Different phenotypes of reactive astrocytes have previously been characterized, including A1-like neurotoxic and A2-like neuroprotective subtypes. However, the precise impact of Tregs on astrocyte reactivity and phenotypes in AD still remains poorly defined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We assessed the impact of Treg immunomodulation on astrocyte reactivity in a mouse model of AD-like amyloid pathology. Using 3D imaging, we carried out extensive morphological analyses of astrocytes following either depletion or amplification of Tregs. We further assessed the expression of several A1- and A2-like markers by immunofluorescence and RT-qPCR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Modulation of Tregs did not significantly impact the magnitude of global astrocyte reactivity in the brain nor in the close vicinity of cortical amyloid deposits. We did not observe changes in the number, morphology, or branching complexity of astrocytes according to immunomodulation of Tregs. However, early transient depletion of Tregs modulated the balance of reactive astrocyte subtypes, resulting in increased C3-positive A1-like phenotypes associated with amyloid deposits. Conversely, early depletion of Tregs decreased markers of A2-like phenotypes of reactive astrocytes associated with larger amyloid deposits. Intriguingly, modulation of Tregs also impacted the cerebral expression of several markers of A1-like subsets in healthy mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study suggests that Tregs contribute to modulate and fine-tune the balance of reactive astrocyte subtypes in AD-like amyloid pathology, by dampening C3-positive astrocytes in favor of A2-like phenotypes. This effect of Tregs may partly relate to their capacity at modulating steady state astrocyte reactivity and homeostasis. Our data further highlight the need for refined markers of astrocytes subsets and strategy of analysis for better deciphering the complexity of astrocyte reactivity in neurodegeneration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-023-02702-3","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T14:02:45Z","timestamp":1678284165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology"],"prefix":"10.1186","volume":"20","author":[{"given":"Gr\u00e9goire","family":"Stym-Popper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Chaigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Rupra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Demetriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Fouquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cira","family":"Dansokho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Toly-Ndour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Doroth\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"2702_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here\u202f? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"2702_CR2","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566-581.e9.","journal-title":"Immunity"},{"key":"2702_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276\u201390.","journal-title":"Cell"},{"key":"2702_CR4","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 2019;27:1293-1306.e6.","journal-title":"Cell Rep"},{"key":"2702_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nrn1870","volume":"7","author":"G Seifert","year":"2006","unstructured":"Seifert G, Schilling K, Steinh\u00e4user C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci. 2006;7:194\u2013206.","journal-title":"Nat Rev Neurosci"},{"key":"2702_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","volume":"108","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Wheeler MA, Quintana FJ. Astrocyte crosstalk in CNS inflammation. Neuron. 2020;108:608\u201322.","journal-title":"Neuron"},{"key":"2702_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fncel.2015.00278","volume":"9","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, Carrillo-de Sauvage MA, Ceyz\u00e9riat K, Escartin C. Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 2015;9:278.","journal-title":"Front Cell Neurosci"},{"key":"2702_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7\u201335.","journal-title":"Acta Neuropathol"},{"key":"2702_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2013.12.030","volume":"565","author":"MA Anderson","year":"2014","unstructured":"Anderson MA, Ao Y, Sofroniew MV. Heterogeneity of reactive astrocytes. Neurosci Lett. 2014;565:23\u20139.","journal-title":"Neurosci Lett"},{"key":"2702_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"2702_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/brainsci10080503","volume":"10","author":"A King","year":"2020","unstructured":"King A, Szekely B, Calapkulu E, Ali H, Rios F, Jones S, et al. The increased densities, but different distributions, of both C3 and S100A10 immunopositive astrocyte-like cells in Alzheimer\u2019s disease brains suggest possible roles for both A1 and A2 astrocytes in the disease pathogenesis. Brain Sci. 2020;10:503.","journal-title":"Brain Sci"},{"key":"2702_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1096\/fj.12-208660","volume":"27","author":"AW Kraft","year":"2013","unstructured":"Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, Wang Y, et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP\/PS1 mice. FASEB J. 2013;27:187\u201398.","journal-title":"FASEB J"},{"key":"2702_CR13","doi-asserted-by":"publisher","first-page":"eaaf6295","DOI":"10.1126\/scitranslmed.aaf6295","volume":"9","author":"Q Shi","year":"2017","unstructured":"Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice. Sci Transl Med. 2017;9:eaaf6295.","journal-title":"Sci Transl Med."},{"key":"2702_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann Neurol. 2018;83:544\u201352.","journal-title":"Ann Neurol"},{"key":"2702_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-015-0317-5","volume":"12","author":"BM Rosset","year":"2015","unstructured":"Rosset BM, Lui G, Dansokho C, Chaigneau T, Doroth\u00e9e G. Vaccine-induced A\u03b2-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer\u2019s disease. J Neuroinflammation. 2015;12:95.","journal-title":"J Neuroinflammation"},{"key":"2702_CR16","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1073\/pnas.0506209103","volume":"103","author":"A Monsonego","year":"2006","unstructured":"Monsonego A, Imitola J, Petrovic S, Zota V, Nemirovsky A, Baron R, et al. A\u03b2-induced meningoencephalitis is IFN-\u03b3-dependent and is associated with T cell-dependent clearance of A\u03b2 in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103:5048\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2702_CR17","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.1200947","volume":"190","author":"TC Browne","year":"2013","unstructured":"Browne TC, McQuillan K, McManus RM, O\u2019Reilly J-A, Mills KHG, Lynch MA. IFN-\u03b3 production by amyloid \u03b2-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer\u2019s disease. J Immunol. 2013;190:2241\u201351.","journal-title":"J Immunol"},{"key":"2702_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.nbd.2008.12.015","volume":"34","author":"C Cao","year":"2009","unstructured":"Cao C, Arendash GW, Dickson A, Mamcarz MB, Lin X, Ethell DW. A\u03b2-specific Th2 cells provide cognitive and pathological benefits to Alzheimer\u2019s mice without infiltrating the CNS. Neurobiol Dis. 2009;34:63\u201370.","journal-title":"Neurobiol Dis"},{"key":"2702_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.nbd.2006.03.008","volume":"23","author":"DW Ethell","year":"2006","unstructured":"Ethell DW, Shippy D, Cao C, Cracchiolo JR, Runfeldt M, Blake B, et al. A\u03b2-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer\u2019s mice. Neurobiol Dis. 2006;23:351\u201361.","journal-title":"Neurobiol Dis"},{"key":"2702_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/brain\/aww270","volume":"140","author":"C Laurent","year":"2017","unstructured":"Laurent C, Doroth\u00e9e G, Hunot S, Martin E, Monnet Y, Duchamp M, et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain. 2017;140:184\u2013200.","journal-title":"Brain"},{"key":"2702_CR21","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. 2016;139:1237\u201351.","journal-title":"Brain"},{"key":"2702_CR22","doi-asserted-by":"publisher","first-page":"69347","DOI":"10.18632\/oncotarget.12469","volume":"7","author":"H Baek","year":"2016","unstructured":"Baek H, Ye M, Kang GH, Lee C, Lee G, Bin CD, et al. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer\u2019s disease model. Oncotarget. 2016;7:69347\u201357.","journal-title":"Oncotarget"},{"key":"2702_CR23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/brain\/awx109","volume":"140","author":"S Alves","year":"2017","unstructured":"Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, et al. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer\u2019s disease mice. Brain. 2017;140:826\u201342.","journal-title":"Brain"},{"key":"2702_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","volume":"599","author":"KA Guttenplan","year":"2021","unstructured":"Guttenplan KA, Weigel MK, Prakash P, Wijewardhane PR, Hasel P, Rufen-Blanchette U, et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature. 2021;599:102\u20137.","journal-title":"Nature"},{"key":"2702_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk A, Wan YW, Swartzlander DB, Chen F, Cole A, Propson NE, et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s disease. Neuron. 2018;100:1337-1353.e5.","journal-title":"Neuron"},{"key":"2702_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","volume":"85","author":"H Lian","year":"2015","unstructured":"Lian H, Yang L, Cole A, Sun L, Chiang ACA, Fowler SW, et al. NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease. Neuron. 2015;85:101\u201315.","journal-title":"Neuron"},{"key":"2702_CR27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","volume":"131","author":"B Stevens","year":"2007","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164\u201378.","journal-title":"Cell"},{"key":"2702_CR28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"2702_CR29","doi-asserted-by":"publisher","first-page":"7967","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif AM, Spinrad A, et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat Commun. 2015;6:7967.","journal-title":"Nat Commun"},{"key":"2702_CR30","doi-asserted-by":"publisher","first-page":"E1896","DOI":"10.1073\/pnas.1800165115","volume":"115","author":"LE Clarke","year":"2018","unstructured":"Clarke LE, Liddelow SA, Chakraborty C, M\u00fcnch AE, Heiman M, Barres BA. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A. 2018;115:E1896\u2013905.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2702_CR31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/jcp.26918","volume":"234","author":"X Xu","year":"2018","unstructured":"Xu X, Zhang A, Zhu Y, He W, Di W, Fang Y, et al. MFG-E8 reverses microglial-induced neurotoxic astrocyte (A1) via NF-\u03baB and PI3K-Akt pathways. J Cell Physiol. 2018;234:904\u201314.","journal-title":"J Cell Physiol"},{"key":"2702_CR32","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41593-021-00905-6","volume":"24","author":"P Hasel","year":"2021","unstructured":"Hasel P, Rose IVL, Sadick JS, Kim RD, Liddelow SA. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci. 2021;24:1475\u201387.","journal-title":"Nat Neurosci"},{"key":"2702_CR33","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick JS, O\u2019Dea MR, Hasel P, Dykstra T, Faustin A, Liddelow SA. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron. 2022;110:1788-1805.e10.","journal-title":"Neuron"},{"key":"2702_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41467-021-27702-w","volume":"13","author":"Z Jiwaji","year":"2022","unstructured":"Jiwaji Z, Tiwari SS, Avil\u00e9s-Reyes RX, Hooley M, Hampton D, Torvell M, et al. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and A\u00df pathology. Nat Commun. 2022;13:135.","journal-title":"Nat Commun"},{"key":"2702_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40478-018-0606-1","volume":"6","author":"K Ceyz\u00e9riat","year":"2018","unstructured":"Ceyz\u00e9riat K, Ben Haim L, Denizot A, Pommier D, Matos M, Guillemaud O, et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6:104.","journal-title":"Acta Neuropathol Commun"},{"key":"2702_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat Neurosci. 2020;23:701\u20136.","journal-title":"Nat Neurosci"},{"key":"2702_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312\u201325.","journal-title":"Nat Neurosci"},{"key":"2702_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41583-020-0264-8","volume":"21","author":"X Yu","year":"2020","unstructured":"Yu X, Nagai J, Khakh BS. Improved tools to study astrocytes. Nat Rev Neurosci. 2020;21:121\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"2702_CR39","doi-asserted-by":"publisher","first-page":"17513","DOI":"10.1073\/pnas.0602841103","volume":"103","author":"U Wilhelmsson","year":"2006","unstructured":"Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A. 2006;103:17513\u20138.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02702-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02702-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02702-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T14:07:31Z","timestamp":1678284451000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02702-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2702"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02702-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"assertion":[{"value":"26 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols involving animal studies have been approved by the Charles Darwin Ethical Committee for Animal Studies and were carried out in compliance with European legislation on animal care and scientific experimentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}